Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?

Cancer. 2014 Apr 15;120(8):1282. doi: 10.1002/cncr.28559. Epub 2014 Jan 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma / therapy*
  • Female
  • Humans
  • Male
  • Neoplasm Recurrence, Local / pathology*
  • Neoplasm Recurrence, Local / therapy*
  • Neoplasm, Residual / pathology*
  • Neoplasm, Residual / therapy*
  • Rectal Neoplasms / pathology*
  • Rectal Neoplasms / therapy*